Zacks Investment ResearchThu, 23 Apr 2026 14:36:26 GMTINBX Stock Up on Upbeat Clinical Update From Colorectal Cancer StudyINBX+7.89%
Seeking AlphaWed, 22 Apr 2026 21:36:07 GMTInhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can ContinueINBX+7.89%
BenzingaWed, 22 Apr 2026 18:20:53 GMTLarge Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock SurgesINBX+7.89%